All data is delayed
See More

Cipla Medpro under investigation

Sep 21 2012 17:50
I-Net Bridge
Johannesburg - Pharmaceutical group Cipla Medpro South Africa [JSE:CMP) said on Friday it had received notification from the Takeover Regulation Panel (TRP) that it intended to conduct an investigation into the affairs of the company relating to a potential affected transaction.

The complaint was lodged on behalf of certain shareholders‚ among whom includes the company’s suspended CEO.

The details of the other shareholders have not yet been disclosed to the TRP.

“The company has confirmed to the TRP that it will cooperate in any way possible to ensure this matter is resolved as quickly as possible.

*Follow Fin24 on Twitter, Facebook, Google+ and Pinterest.


Read Fin24’s Comments Policy publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Company Snapshot

We're talking about:


With infrastructure spending having been identified as one of the key focus areas of the National Development Plan, tradesmen will continue to play a critical role in growing the South African economy through their skills..

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

A 30% a month return on investment is:

Previous results · Suggest a vote